Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 620

1.

Triple uptake inhibitors: therapeutic potential in depression and beyond.

Chen Z, Skolnick P.

Expert Opin Investig Drugs. 2007 Sep;16(9):1365-77. Review.

PMID:
17714023
2.

Milnacipran and selective serotonin reuptake inhibitors in major depression.

Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.

Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:41-6. Review.

PMID:
8923126
3.

Designing new treatments for depression and anxiety.

Chen Z, Yang J, Tobak A.

IDrugs. 2008 Mar;11(3):189-97. Review.

PMID:
18311656
4.

Comparative efficacy of antidepressants.

Kasper S, Fuger J, Möller HJ.

Drugs. 1992;43 Suppl 2:11-22; discussion 22-3. Review.

PMID:
1378369
5.

Contemporary management of depression.

Andrews JM, Nemeroff CB.

Am J Med. 1994 Dec 19;97(6A):24S-32S. Review.

PMID:
7992823
6.

Current trends in the development of new antidepressants.

Pacher P, Kohegyi E, Kecskemeti V, Furst S.

Curr Med Chem. 2001 Feb;8(2):89-100. Review.

PMID:
11172668
7.
8.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
9.

[The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review].

Miller A, Rabe-Jabłońska J.

Psychiatr Pol. 2005 Jan-Feb;39(1):21-32. Review. Polish.

PMID:
15771151
10.

[Fluoxetine: an update of its use in major depressive disorder in adults].

Gourion D, Perrin E, Quintin P.

Encephale. 2004 Jul-Aug;30(4):392-9. Review. French.

PMID:
15597466
11.

Pharmacology of antidepressants: selectivity or multiplicity?

Westenberg HG.

J Clin Psychiatry. 1999;60 Suppl 17:4-8; discussion 46-8. Review.

12.

Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.

Mukai Y, Tampi RR.

Clin Ther. 2009 May;31(5):945-61. doi: 10.1016/j.clinthera.2009.05.016. Review.

PMID:
19539096
13.
14.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
15.

Duloxetine pharmacology: profile of a dual monoamine modulator.

Karpa KD, Cavanaugh JE, Lakoski JM.

CNS Drug Rev. 2002 Winter;8(4):361-76. Review.

16.

Dual monoamine modulation for improved treatment of major depressive disorder.

Tran PV, Bymaster FP, McNamara RK, Potter WZ.

J Clin Psychopharmacol. 2003 Feb;23(1):78-86. Review. Erratum in: J Clin Psychopharmacol. 2003 Aug;23(4):425.

PMID:
12544378
18.

The dual-action hypothesis: does pharmacology matter?

Shelton RC.

J Clin Psychiatry. 2004;65 Suppl 17:5-10. Review.

19.

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.

Felton TM, Kang TB, Hjorth S, Auerbach SB.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Mar;367(3):297-305.

PMID:
12644903
20.

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

Ruhé HG, Huyser J, Swinkels JA, Schene AH.

J Clin Psychiatry. 2006 Dec;67(12):1836-55. Review.

PMID:
17194261
Items per page

Supplemental Content

Support Center